US biotech Abcuro has reeled in $200 million in third-round financing that should allow it to complete its pivotal trial of ...

Inclusion body myositis (IBM) is the most prevalent muscle-wasting disease ... highlights the need for a core outcome set to consistently assess treatment response and disease progression in IBM, ...

Sporadic inclusion body myositis (sIBM) presents with a characteristic ... pathways might prove helpful in arresting disease progression. sIBM is often misdiagnosed as polymyositis or other ...

sIBM is a complex disorder, the underlying cause of which is unclear. The observation that the intact muscle fibers are invaded by T lymphocytes, whereas the vacuolated fibers lack T-cell ...

A mere day into his second term in office and President Donald Trump has already made good on his vow to terminate federal government diversity, equity and inclusion programs which he has ...